|
Thomas Neyarapally spearheads and implements the strategic vision for the expansion, protection and monetization of Gene Network Sciences’ intellectual property. Before joining GNS, Neyarapally served as an associate in the New York office of the intellectual property firm Frommer, Lawrence & Haug LLP, where he focused on transactional, product development, and Hatch-Waxman litigation matters for clients in the pharmaceutical and biotech industries. Neyarapally previously was an associate in the corporate department at Chadbourne & Parke, LLP, and held the position of analyst at Arthur D. Little. Neyarapally holds a J.D. and an M.B.A. from Cornell University. While attending Cornell’s Johnson Graduate School of Management, he served as a partner at BR Ventures, the only student-run venture capital firm in the United States. Neyarapally graduated from the University of Connecticut with a B.S. in chemical engineering. | 